Biopharma Company Ready to Run ATNM product picked for HIV clinical trial Good day everyone, Today we are revisiting a stock we covered a couple weeks...
FDA Approves Tazverik (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma
Article Link: FDA Approves Tazverik (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma CAMBRIDGE, Mass.–(BUSINES...
(NASDAQ: GNPX) Now Crossing $2/share in Pre-Market Trading, Full Report
Genprex Makes Significant FDA Announcement (GNPX) After Hours close at $1.38/share / Volume 53.6M shares traded, on watch for continuation… Fast Track...
FDA Approves Tepezza (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED)
Article Link: FDA Approves Tepezza (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED) DUBLIN–(BUSINESS WIRE)–...
Over 250% in bookable gains on our last 4 reports within 30 days. New tiny float NASDAQ report will be available to view Tuesday 1/21/20. Let’s continue this hot streak!
Low Float NASDAQ Stock Looking Oversold Biopharma gem at a good value Good day everyone, First, welcome to all our new members and hello to all who ha...
FDA Approves Ozempic (semaglutide) for Cardiovascular Risk Reduction in Adults with Type 2 Diabetes and Known Heart Disease
Article Link: FDA Approves Ozempic (semaglutide) for Cardiovascular Risk Reduction in Adults with Type 2 Diabetes and Known Heart Disease ...
Tiny float stock report coming tomorrow on a company operating in two hot verticals
Tiny Float – Potential Runner Two hot market sectors and way under the radar Get this low float alert first by texting the keyword “TRADER...
FDA Approves Numbrino (cocaine hydrochloride) Nasal Solution for Nasal Anesthesia
Article Link: FDA Approves Numbrino (cocaine hydrochloride) Nasal Solution for Nasal Anesthesia PHILADELPHIA, Jan. 13, 2020 /PRNewswire/ ...
FDA Approves Valtoco (diazepam nasal spray) as a Seizure Rescue Treatment
Article Link: FDA Approves Valtoco (diazepam nasal spray) as a Seizure Rescue Treatment SAN DIEGO, CA – January 13, 2020 – Neurelis, Inc....
NYSE Biopharma New Report Poised for Gains This Week
ATNM could change the way we treat cancer Good day everyone, Today we are revisiting a stock we’ve covered in the past, Actinium Pharmaceuticals, Inc....